ATE262324T1 - Verkapslung einer untereinheit des bovinen herpes virus typ-1 in wässrigen lösungsmitteln als impfstoff. - Google Patents

Verkapslung einer untereinheit des bovinen herpes virus typ-1 in wässrigen lösungsmitteln als impfstoff.

Info

Publication number
ATE262324T1
ATE262324T1 AT98302863T AT98302863T ATE262324T1 AT E262324 T1 ATE262324 T1 AT E262324T1 AT 98302863 T AT98302863 T AT 98302863T AT 98302863 T AT98302863 T AT 98302863T AT E262324 T1 ATE262324 T1 AT E262324T1
Authority
AT
Austria
Prior art keywords
vaccine
subunit
encapsulation
virus type
herpes virus
Prior art date
Application number
AT98302863T
Other languages
English (en)
Inventor
Manuel Campos
Patrick Frenchick
Frederick Clark
Paul Offit
Charlotte Moser
Tully Speaker
Original Assignee
Pfizer
Univ Temple
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Univ Temple, Philadelphia Children Hospital filed Critical Pfizer
Application granted granted Critical
Publication of ATE262324T1 publication Critical patent/ATE262324T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/813—Viral vaccine for bovine species, e.g. cattle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT98302863T 1997-04-23 1998-04-14 Verkapslung einer untereinheit des bovinen herpes virus typ-1 in wässrigen lösungsmitteln als impfstoff. ATE262324T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4417297P 1997-04-23 1997-04-23

Publications (1)

Publication Number Publication Date
ATE262324T1 true ATE262324T1 (de) 2004-04-15

Family

ID=21930892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98302863T ATE262324T1 (de) 1997-04-23 1998-04-14 Verkapslung einer untereinheit des bovinen herpes virus typ-1 in wässrigen lösungsmitteln als impfstoff.

Country Status (15)

Country Link
US (1) US6270800B1 (de)
EP (1) EP0873752B1 (de)
JP (1) JPH10316586A (de)
CN (1) CN1196931A (de)
AR (1) AR012009A1 (de)
AT (1) ATE262324T1 (de)
AU (1) AU713639B2 (de)
BR (1) BR9801435A (de)
CA (1) CA2229430A1 (de)
DE (1) DE69822542T2 (de)
DK (1) DK0873752T3 (de)
ES (1) ES2216242T3 (de)
NZ (1) NZ330251A (de)
PT (1) PT873752E (de)
ZA (1) ZA983327B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855316B1 (en) * 1994-02-14 2005-02-15 University Of Hawaii Baculovirus produced Plasmodium falciparum vaccine
CA2361377C (en) * 1999-02-05 2009-02-03 Alk-Abello A/S Novel mucosal delivery system
KR20010003853A (ko) * 1999-06-25 2001-01-15 박호군 경구용 백신으로 사용할 수 있는 알긴산염 마이크로스피어 및그 제조방법
US20030100106A1 (en) * 2000-02-08 2003-05-29 Chang Sandra P. Baculovirus produced Plasmodium falciparum vaccine
US7037681B2 (en) * 2000-02-08 2006-05-02 University Of Hawaii Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants
JP4370451B2 (ja) * 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
US8039015B2 (en) 2004-12-08 2011-10-18 Speaker Tycho J Microencapsulation product and process
WO2013166681A1 (zh) * 2012-05-10 2013-11-14 聚和国际股份有限公司 用于制备微胶囊的组合物及用其所制得的药物
WO2014193908A1 (en) 2013-05-28 2014-12-04 Capsulent Products containing charged polymer complex microcapsules and method of use
CN107973840A (zh) * 2017-01-13 2018-05-01 浙江海隆生物科技有限公司 CHO细胞表达牛传染性病气管炎病毒gD蛋白及其亚单位疫苗的制备和应用
CN112180089A (zh) * 2020-09-21 2021-01-05 黑龙江八一农垦大学 一种牛疱疹病毒i型抗体阻断elisa检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
US5462734A (en) * 1990-11-02 1995-10-31 Wisconsin Alumni Research Foundation Bovine herpesvirus vaccine and method of using same
DE69530227T2 (de) * 1994-04-15 2004-04-01 Temple University Methode zum einkapseln mittels eines wässrigen lösungsmittels und mikrokapseln
US5686113A (en) * 1995-03-21 1997-11-11 Temple University Of The Commonwealth System Of Higher Education Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses

Also Published As

Publication number Publication date
DE69822542T2 (de) 2004-08-05
EP0873752B1 (de) 2004-03-24
EP0873752A3 (de) 2001-02-07
CA2229430A1 (en) 1998-10-23
EP0873752A2 (de) 1998-10-28
NZ330251A (en) 1998-11-25
AR012009A1 (es) 2000-09-13
BR9801435A (pt) 2000-01-11
AU713639B2 (en) 1999-12-09
ES2216242T3 (es) 2004-10-16
ZA983327B (en) 1999-10-21
PT873752E (pt) 2004-07-30
JPH10316586A (ja) 1998-12-02
DK0873752T3 (da) 2004-05-10
DE69822542D1 (de) 2004-04-29
US6270800B1 (en) 2001-08-07
CN1196931A (zh) 1998-10-28
AU6351198A (en) 1998-11-12

Similar Documents

Publication Publication Date Title
DZ2462A1 (fr) Vaccin antigrippal.
NO20000257L (no) Modifisert immunogent pneumolysin, sammensetninger omfattende dette samt anvendelse derav som vaksine
DK1210113T3 (da) Kombinerede vaccinepræparater
ATE275631T1 (de) Rekombinanter venezolanische-equine- pferdeenzephalitis-virusimpstoff
NO986208D0 (no) Vandige peptidformuleringer
NO20003302L (no) Vaksine
DE69835557D1 (de) Wässrige Tintenzusammensetzungen
IL181468A0 (en) E2 subunit vaccine comprising recombinant pestivirus e2 protein
ID30459A (id) Peptida-peptida makrosiklik yang aktif melawan virus hepatitis c
FI970277L (fi) Influenssavirusalayksikön konjugaatteja
ATE262324T1 (de) Verkapslung einer untereinheit des bovinen herpes virus typ-1 in wässrigen lösungsmitteln als impfstoff.
DE69420357D1 (de) Wässrige, alkalische Zubereitung
EP0366238A3 (de) Influenzavakzin-Polypeptide
DE60019993D1 (de) Wässrige Lysinlösungen
DE59908817D1 (de) Wässrige zubereitungen
ATE519775T1 (de) Rekombinante untereinheiten-impfstoffe
NZ230459A (en) Method of purifying the ha2 subunit of the influenza virus ha protein
BR1100968A (pt) Formulação de vacina de subunidade
ITMI992410A0 (it) Vaccino per hiv
GB9703202D0 (en) HIV vaccine
GB9725241D0 (en) Hiv vaccine
NO20002231D0 (no) Fysiologisk akseptable vandige løsninger
ES1038368Y (es) Sobre reutilizable perfeccionado.
ES1037044Y (es) Sobre perfeccionado.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0873752

Country of ref document: EP

REN Ceased due to non-payment of the annual fee